Global Circulating Tumor Cell Diagnostics Market Size, Status and Forecast 2020-2026

May 2020 | 127 pages | ID: G7DCE273D9D2EN
QYResearch

Abstracts

This report focuses on the global Circulating Tumor Cell Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Circulating Tumor Cell Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Janssen Diagnostics
• Advanced Cell Diagnostics
• Aviva Biosciences
• Biocept Inc
• Biofluidica Inc.
• CellTraffix Inc.
• Clearbridge BioMedics Pte Ltd
• Epic Sciences Inc.
• Fluxion Biosciences Inc.
• ScreenCell
• Silicon Biosystems
• Sysmex Corporation
• Greiner Bio-One GmbH
• AdnaGen AG
• Apocell Inc
• Biocep Ltd
• Canopus Bioscience Ltd
• Creatv Microtech Inc
• Ikonisys Inc
• IV Diagnostics Inc
• Miltenyi Biotech GmbH
• Nanostring Technologies Inc
• Rarecells Diagnostics.
• Vitatex Inc

Market segment by Type, the product can be split into

• CTC Enrichment
• CTC Detection
• CTC Analysis

Market segment by Application, split into

• Tumorigenesis research
• EMT biomarkers development
• Cancer stem cell research
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Circulating Tumor Cell Diagnostics status, future forecast, growth opportunity, key market and key players.
• To present the Circulating Tumor Cell Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Circulating Tumor Cell Diagnostics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Circulating Tumor Cell Diagnostics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Circulating Tumor Cell Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 CTC Enrichment
  1.4.3 CTC Detection
  1.4.4 CTC Analysis
1.5 Market by Application
  1.5.1 Global Circulating Tumor Cell Diagnostics Market Share by Application: 2020 VS 2026
  1.5.2 Tumorigenesis research
  1.5.3 EMT biomarkers development
  1.5.4 Cancer stem cell research
  1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Circulating Tumor Cell Diagnostics Market Perspective (2015-2026)
2.2 Circulating Tumor Cell Diagnostics Growth Trends by Regions
  2.2.1 Circulating Tumor Cell Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Circulating Tumor Cell Diagnostics Historic Market Share by Regions (2015-2020)
  2.2.3 Circulating Tumor Cell Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Circulating Tumor Cell Diagnostics Market Growth Strategy
  2.3.6 Primary Interviews with Key Circulating Tumor Cell Diagnostics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Circulating Tumor Cell Diagnostics Players by Market Size
  3.1.1 Global Top Circulating Tumor Cell Diagnostics Players by Revenue (2015-2020)
  3.1.2 Global Circulating Tumor Cell Diagnostics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Circulating Tumor Cell Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Circulating Tumor Cell Diagnostics Market Concentration Ratio
  3.2.1 Global Circulating Tumor Cell Diagnostics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell Diagnostics Revenue in 2019
3.3 Circulating Tumor Cell Diagnostics Key Players Head office and Area Served
3.4 Key Players Circulating Tumor Cell Diagnostics Product Solution and Service
3.5 Date of Enter into Circulating Tumor Cell Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Circulating Tumor Cell Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Type (2021-2026)

5 CIRCULATING TUMOR CELL DIAGNOSTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
5.2 Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Circulating Tumor Cell Diagnostics Market Size (2015-2020)
6.2 Circulating Tumor Cell Diagnostics Key Players in North America (2019-2020)
6.3 North America Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
6.4 North America Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Circulating Tumor Cell Diagnostics Market Size (2015-2020)
7.2 Circulating Tumor Cell Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
7.4 Europe Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)

8 CHINA

8.1 China Circulating Tumor Cell Diagnostics Market Size (2015-2020)
8.2 Circulating Tumor Cell Diagnostics Key Players in China (2019-2020)
8.3 China Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
8.4 China Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Circulating Tumor Cell Diagnostics Market Size (2015-2020)
9.2 Circulating Tumor Cell Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
9.4 Japan Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Circulating Tumor Cell Diagnostics Market Size (2015-2020)
10.2 Circulating Tumor Cell Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)

11 INDIA

11.1 India Circulating Tumor Cell Diagnostics Market Size (2015-2020)
11.2 Circulating Tumor Cell Diagnostics Key Players in India (2019-2020)
11.3 India Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
11.4 India Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Circulating Tumor Cell Diagnostics Market Size (2015-2020)
12.2 Circulating Tumor Cell Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Janssen Diagnostics
  13.1.1 Janssen Diagnostics Company Details
  13.1.2 Janssen Diagnostics Business Overview and Its Total Revenue
  13.1.3 Janssen Diagnostics Circulating Tumor Cell Diagnostics Introduction
  13.1.4 Janssen Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020))
  13.1.5 Janssen Diagnostics Recent Development
13.2 Advanced Cell Diagnostics
  13.2.1 Advanced Cell Diagnostics Company Details
  13.2.2 Advanced Cell Diagnostics Business Overview and Its Total Revenue
  13.2.3 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Introduction
  13.2.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  13.2.5 Advanced Cell Diagnostics Recent Development
13.3 Aviva Biosciences
  13.3.1 Aviva Biosciences Company Details
  13.3.2 Aviva Biosciences Business Overview and Its Total Revenue
  13.3.3 Aviva Biosciences Circulating Tumor Cell Diagnostics Introduction
  13.3.4 Aviva Biosciences Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  13.3.5 Aviva Biosciences Recent Development
13.4 Biocept Inc
  13.4.1 Biocept Inc Company Details
  13.4.2 Biocept Inc Business Overview and Its Total Revenue
  13.4.3 Biocept Inc Circulating Tumor Cell Diagnostics Introduction
  13.4.4 Biocept Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  13.4.5 Biocept Inc Recent Development
13.5 Biofluidica Inc.
  13.5.1 Biofluidica Inc. Company Details
  13.5.2 Biofluidica Inc. Business Overview and Its Total Revenue
  13.5.3 Biofluidica Inc. Circulating Tumor Cell Diagnostics Introduction
  13.5.4 Biofluidica Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  13.5.5 Biofluidica Inc. Recent Development
13.6 CellTraffix Inc.
  13.6.1 CellTraffix Inc. Company Details
  13.6.2 CellTraffix Inc. Business Overview and Its Total Revenue
  13.6.3 CellTraffix Inc. Circulating Tumor Cell Diagnostics Introduction
  13.6.4 CellTraffix Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  13.6.5 CellTraffix Inc. Recent Development
13.7 Clearbridge BioMedics Pte Ltd
  13.7.1 Clearbridge BioMedics Pte Ltd Company Details
  13.7.2 Clearbridge BioMedics Pte Ltd Business Overview and Its Total Revenue
  13.7.3 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Introduction
  13.7.4 Clearbridge BioMedics Pte Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  13.7.5 Clearbridge BioMedics Pte Ltd Recent Development
13.8 Epic Sciences Inc.
  13.8.1 Epic Sciences Inc. Company Details
  13.8.2 Epic Sciences Inc. Business Overview and Its Total Revenue
  13.8.3 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Introduction
  13.8.4 Epic Sciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  13.8.5 Epic Sciences Inc. Recent Development
13.9 Fluxion Biosciences Inc.
  13.9.1 Fluxion Biosciences Inc. Company Details
  13.9.2 Fluxion Biosciences Inc. Business Overview and Its Total Revenue
  13.9.3 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Introduction
  13.9.4 Fluxion Biosciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  13.9.5 Fluxion Biosciences Inc. Recent Development
13.10 ScreenCell
  13.10.1 ScreenCell Company Details
  13.10.2 ScreenCell Business Overview and Its Total Revenue
  13.10.3 ScreenCell Circulating Tumor Cell Diagnostics Introduction
  13.10.4 ScreenCell Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  13.10.5 ScreenCell Recent Development
13.11 Silicon Biosystems
  10.11.1 Silicon Biosystems Company Details
  10.11.2 Silicon Biosystems Business Overview and Its Total Revenue
  10.11.3 Silicon Biosystems Circulating Tumor Cell Diagnostics Introduction
  10.11.4 Silicon Biosystems Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.11.5 Silicon Biosystems Recent Development
13.12 Sysmex Corporation
  10.12.1 Sysmex Corporation Company Details
  10.12.2 Sysmex Corporation Business Overview and Its Total Revenue
  10.12.3 Sysmex Corporation Circulating Tumor Cell Diagnostics Introduction
  10.12.4 Sysmex Corporation Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.12.5 Sysmex Corporation Recent Development
13.13 Greiner Bio-One GmbH
  10.13.1 Greiner Bio-One GmbH Company Details
  10.13.2 Greiner Bio-One GmbH Business Overview and Its Total Revenue
  10.13.3 Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Introduction
  10.13.4 Greiner Bio-One GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.13.5 Greiner Bio-One GmbH Recent Development
13.14 AdnaGen AG
  10.14.1 AdnaGen AG Company Details
  10.14.2 AdnaGen AG Business Overview and Its Total Revenue
  10.14.3 AdnaGen AG Circulating Tumor Cell Diagnostics Introduction
  10.14.4 AdnaGen AG Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.14.5 AdnaGen AG Recent Development
13.15 Apocell Inc
  10.15.1 Apocell Inc Company Details
  10.15.2 Apocell Inc Business Overview and Its Total Revenue
  10.15.3 Apocell Inc Circulating Tumor Cell Diagnostics Introduction
  10.15.4 Apocell Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.15.5 Apocell Inc Recent Development
13.16 Biocep Ltd
  10.16.1 Biocep Ltd Company Details
  10.16.2 Biocep Ltd Business Overview and Its Total Revenue
  10.16.3 Biocep Ltd Circulating Tumor Cell Diagnostics Introduction
  10.16.4 Biocep Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.16.5 Biocep Ltd Recent Development
13.17 Canopus Bioscience Ltd
  10.17.1 Canopus Bioscience Ltd Company Details
  10.17.2 Canopus Bioscience Ltd Business Overview and Its Total Revenue
  10.17.3 Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Introduction
  10.17.4 Canopus Bioscience Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.17.5 Canopus Bioscience Ltd Recent Development
13.18 Creatv Microtech Inc
  10.18.1 Creatv Microtech Inc Company Details
  10.18.2 Creatv Microtech Inc Business Overview and Its Total Revenue
  10.18.3 Creatv Microtech Inc Circulating Tumor Cell Diagnostics Introduction
  10.18.4 Creatv Microtech Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.18.5 Creatv Microtech Inc Recent Development
13.19 Ikonisys Inc
  10.19.1 Ikonisys Inc Company Details
  10.19.2 Ikonisys Inc Business Overview and Its Total Revenue
  10.19.3 Ikonisys Inc Circulating Tumor Cell Diagnostics Introduction
  10.19.4 Ikonisys Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.19.5 Ikonisys Inc Recent Development
13.20 IV Diagnostics Inc
  10.20.1 IV Diagnostics Inc Company Details
  10.20.2 IV Diagnostics Inc Business Overview and Its Total Revenue
  10.20.3 IV Diagnostics Inc Circulating Tumor Cell Diagnostics Introduction
  10.20.4 IV Diagnostics Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.20.5 IV Diagnostics Inc Recent Development
13.21 Miltenyi Biotech GmbH
  10.21.1 Miltenyi Biotech GmbH Company Details
  10.21.2 Miltenyi Biotech GmbH Business Overview and Its Total Revenue
  10.21.3 Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Introduction
  10.21.4 Miltenyi Biotech GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.21.5 Miltenyi Biotech GmbH Recent Development
13.22 Nanostring Technologies Inc
  10.22.1 Nanostring Technologies Inc Company Details
  10.22.2 Nanostring Technologies Inc Business Overview and Its Total Revenue
  10.22.3 Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Introduction
  10.22.4 Nanostring Technologies Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.22.5 Nanostring Technologies Inc Recent Development
13.23 Rarecells Diagnostics.
  10.23.1 Rarecells Diagnostics. Company Details
  10.23.2 Rarecells Diagnostics. Business Overview and Its Total Revenue
  10.23.3 Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Introduction
  10.23.4 Rarecells Diagnostics. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.23.5 Rarecells Diagnostics. Recent Development
13.24 Vitatex Inc
  10.24.1 Vitatex Inc Company Details
  10.24.2 Vitatex Inc Business Overview and Its Total Revenue
  10.24.3 Vitatex Inc Circulating Tumor Cell Diagnostics Introduction
  10.24.4 Vitatex Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
  10.24.5 Vitatex Inc Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Circulating Tumor Cell Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Circulating Tumor Cell Diagnostics Revenue
Table 3. Ranking of Global Top Circulating Tumor Cell Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Circulating Tumor Cell Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CTC Enrichment
Table 6. Key Players of CTC Detection
Table 7. Key Players of CTC Analysis
Table 8. Global Circulating Tumor Cell Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Circulating Tumor Cell Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Circulating Tumor Cell Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Circulating Tumor Cell Diagnostics Market Share by Regions (2015-2020)
Table 12. Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Circulating Tumor Cell Diagnostics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Circulating Tumor Cell Diagnostics Market Growth Strategy
Table 18. Main Points Interviewed from Key Circulating Tumor Cell Diagnostics Players
Table 19. Global Circulating Tumor Cell Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Circulating Tumor Cell Diagnostics Market Share by Players (2015-2020)
Table 21. Global Top Circulating Tumor Cell Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell Diagnostics as of 2019)
Table 22. Global Circulating Tumor Cell Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Circulating Tumor Cell Diagnostics Product Solution and Service
Table 25. Date of Enter into Circulating Tumor Cell Diagnostics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Circulating Tumor Cell Diagnostics Market Size Share by Type (2015-2020)
Table 29. Global Circulating Tumor Cell Diagnostics Revenue Market Share by Type (2021-2026)
Table 30. Global Circulating Tumor Cell Diagnostics Market Size Share by Application (2015-2020)
Table 31. Global Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Circulating Tumor Cell Diagnostics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Circulating Tumor Cell Diagnostics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Circulating Tumor Cell Diagnostics Market Share (2019-2020)
Table 35. North America Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Circulating Tumor Cell Diagnostics Market Share by Type (2015-2020)
Table 37. North America Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Circulating Tumor Cell Diagnostics Market Share by Application (2015-2020)
Table 39. Europe Key Players Circulating Tumor Cell Diagnostics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Circulating Tumor Cell Diagnostics Market Share (2019-2020)
Table 41. Europe Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Circulating Tumor Cell Diagnostics Market Share by Type (2015-2020)
Table 43. Europe Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Circulating Tumor Cell Diagnostics Market Share by Application (2015-2020)
Table 45. China Key Players Circulating Tumor Cell Diagnostics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Circulating Tumor Cell Diagnostics Market Share (2019-2020)
Table 47. China Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 48. China Circulating Tumor Cell Diagnostics Market Share by Type (2015-2020)
Table 49. China Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 50. China Circulating Tumor Cell Diagnostics Market Share by Application (2015-2020)
Table 51. Japan Key Players Circulating Tumor Cell Diagnostics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Circulating Tumor Cell Diagnostics Market Share (2019-2020)
Table 53. Japan Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Circulating Tumor Cell Diagnostics Market Share by Type (2015-2020)
Table 55. Japan Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Circulating Tumor Cell Diagnostics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Circulating Tumor Cell Diagnostics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Circulating Tumor Cell Diagnostics Market Share (2019-2020)
Table 59. Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Circulating Tumor Cell Diagnostics Market Share by Type (2015-2020)
Table 61. Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Circulating Tumor Cell Diagnostics Market Share by Application (2015-2020)
Table 63. India Key Players Circulating Tumor Cell Diagnostics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Circulating Tumor Cell Diagnostics Market Share (2019-2020)
Table 65. India Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 66. India Circulating Tumor Cell Diagnostics Market Share by Type (2015-2020)
Table 67. India Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 68. India Circulating Tumor Cell Diagnostics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Circulating Tumor Cell Diagnostics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Circulating Tumor Cell Diagnostics Market Share (2019-2020)
Table 71. Central & South America Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Circulating Tumor Cell Diagnostics Market Share by Type (2015-2020)
Table 73. Central & South America Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Circulating Tumor Cell Diagnostics Market Share by Application (2015-2020)
Table 75. Janssen Diagnostics Company Details
Table 76. Janssen Diagnostics Business Overview
Table 77. Janssen Diagnostics Product
Table 78. Janssen Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 79. Janssen Diagnostics Recent Development
Table 80. Advanced Cell Diagnostics Company Details
Table 81. Advanced Cell Diagnostics Business Overview
Table 82. Advanced Cell Diagnostics Product
Table 83. Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 84. Advanced Cell Diagnostics Recent Development
Table 85. Aviva Biosciences Company Details
Table 86. Aviva Biosciences Business Overview
Table 87. Aviva Biosciences Product
Table 88. Aviva Biosciences Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 89. Aviva Biosciences Recent Development
Table 90. Biocept Inc Company Details
Table 91. Biocept Inc Business Overview
Table 92. Biocept Inc Product
Table 93. Biocept Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 94. Biocept Inc Recent Development
Table 95. Biofluidica Inc. Company Details
Table 96. Biofluidica Inc. Business Overview
Table 97. Biofluidica Inc. Product
Table 98. Biofluidica Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 99. Biofluidica Inc. Recent Development
Table 100. CellTraffix Inc. Company Details
Table 101. CellTraffix Inc. Business Overview
Table 102. CellTraffix Inc. Product
Table 103. CellTraffix Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 104. CellTraffix Inc. Recent Development
Table 105. Clearbridge BioMedics Pte Ltd Company Details
Table 106. Clearbridge BioMedics Pte Ltd Business Overview
Table 107. Clearbridge BioMedics Pte Ltd Product
Table 108. Clearbridge BioMedics Pte Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 109. Clearbridge BioMedics Pte Ltd Recent Development
Table 110. Epic Sciences Inc. Business Overview
Table 111. Epic Sciences Inc. Product
Table 112. Epic Sciences Inc. Company Details
Table 113. Epic Sciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 114. Epic Sciences Inc. Recent Development
Table 115. Fluxion Biosciences Inc. Company Details
Table 116. Fluxion Biosciences Inc. Business Overview
Table 117. Fluxion Biosciences Inc. Product
Table 118. Fluxion Biosciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 119. Fluxion Biosciences Inc. Recent Development
Table 120. ScreenCell Company Details
Table 121. ScreenCell Business Overview
Table 122. ScreenCell Product
Table 123. ScreenCell Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 124. ScreenCell Recent Development
Table 125. Silicon Biosystems Company Details
Table 126. Silicon Biosystems Business Overview
Table 127. Silicon Biosystems Product
Table 128. Silicon Biosystems Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 129. Silicon Biosystems Recent Development
Table 130. Sysmex Corporation Company Details
Table 131. Sysmex Corporation Business Overview
Table 132. Sysmex Corporation Product
Table 133. Sysmex Corporation Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 134. Sysmex Corporation Recent Development
Table 135. Greiner Bio-One GmbH Company Details
Table 136. Greiner Bio-One GmbH Business Overview
Table 137. Greiner Bio-One GmbH Product
Table 138. Greiner Bio-One GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 139. Greiner Bio-One GmbH Recent Development
Table 140. AdnaGen AG Company Details
Table 141. AdnaGen AG Business Overview
Table 142. AdnaGen AG Product
Table 143. AdnaGen AG Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 144. AdnaGen AG Recent Development
Table 145. Apocell Inc Company Details
Table 146. Apocell Inc Business Overview
Table 147. Apocell Inc Product
Table 148. Apocell Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 149. Apocell Inc Recent Development
Table 150. Biocep Ltd Company Details
Table 151. Biocep Ltd Business Overview
Table 152. Biocep Ltd Product
Table 153. Biocep Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 154. Biocep Ltd Recent Development
Table 155. Canopus Bioscience Ltd Company Details
Table 156. Canopus Bioscience Ltd Business Overview
Table 157. Canopus Bioscience Ltd Product
Table 158. Canopus Bioscience Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 159. Canopus Bioscience Ltd Recent Development
Table 160. Creatv Microtech Inc Company Details
Table 161. Creatv Microtech Inc Business Overview
Table 162. Creatv Microtech Inc Product
Table 163. Creatv Microtech Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 164. Creatv Microtech Inc Recent Development
Table 165. Ikonisys Inc Company Details
Table 166. Ikonisys Inc Business Overview
Table 167. Ikonisys Inc Product
Table 168. Ikonisys Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 169. Ikonisys Inc Recent Development
Table 170. IV Diagnostics Inc Company Details
Table 171. IV Diagnostics Inc Business Overview
Table 172. IV Diagnostics Inc Product
Table 173. IV Diagnostics Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 174. IV Diagnostics Inc Recent Development
Table 175. Miltenyi Biotech GmbH Company Details
Table 176. Miltenyi Biotech GmbH Business Overview
Table 177. Miltenyi Biotech GmbH Product
Table 178. Miltenyi Biotech GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 179. Miltenyi Biotech GmbH Recent Development
Table 180. Nanostring Technologies Inc Company Details
Table 181. Nanostring Technologies Inc Business Overview
Table 182. Nanostring Technologies Inc Product
Table 183. Nanostring Technologies Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 184. Nanostring Technologies Inc Recent Development
Table 185. Rarecells Diagnostics. Company Details
Table 186. Rarecells Diagnostics. Business Overview
Table 187. Rarecells Diagnostics. Product
Table 188. Rarecells Diagnostics. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 189. Rarecells Diagnostics. Recent Development
Table 190. Vitatex Inc Company Details
Table 191. Vitatex Inc Business Overview
Table 192. Vitatex Inc Product
Table 193. Vitatex Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020) (Million US$)
Table 194. Vitatex Inc Recent Development
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Circulating Tumor Cell Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. CTC Enrichment Features
Figure 3. CTC Detection Features
Figure 4. CTC Analysis Features
Figure 5. Global Circulating Tumor Cell Diagnostics Market Share by Application: 2020 VS 2026
Figure 6. Tumorigenesis research Case Studies
Figure 7. EMT biomarkers development Case Studies
Figure 8. Cancer stem cell research Case Studies
Figure 9. Others Case Studies
Figure 10. Circulating Tumor Cell Diagnostics Report Years Considered
Figure 11. Global Circulating Tumor Cell Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Circulating Tumor Cell Diagnostics Market Share by Regions: 2020 VS 2026
Figure 13. Global Circulating Tumor Cell Diagnostics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Circulating Tumor Cell Diagnostics Market Share by Players in 2019
Figure 16. Global Top Circulating Tumor Cell Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell Diagnostics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Circulating Tumor Cell Diagnostics Revenue in 2019
Figure 18. North America Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Circulating Tumor Cell Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Janssen Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Janssen Diagnostics Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 27. Advanced Cell Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 29. Aviva Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Aviva Biosciences Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 31. Biocept Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Biocept Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 33. Biofluidica Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Biofluidica Inc. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 35. CellTraffix Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. CellTraffix Inc. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 37. Clearbridge BioMedics Pte Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Clearbridge BioMedics Pte Ltd Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 39. Epic Sciences Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Epic Sciences Inc. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 41. Fluxion Biosciences Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Fluxion Biosciences Inc. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 43. ScreenCell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. ScreenCell Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 45. Silicon Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 47. Sysmex Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Sysmex Corporation Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 49. Greiner Bio-One GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Greiner Bio-One GmbH Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 51. AdnaGen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. AdnaGen AG Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 53. Apocell Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Apocell Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 55. Biocep Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Biocep Ltd Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 57. Canopus Bioscience Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Canopus Bioscience Ltd Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 59. Creatv Microtech Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Creatv Microtech Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 61. Ikonisys Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Ikonisys Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 63. IV Diagnostics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. IV Diagnostics Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed